Immediate release pharmaceutical formulation
PK144742BActive Publication Date: 2026-08-06ASTRAZENECA AB
0 Cites 0 Cited by
Patent Information
- Application Number
- PK202100303
- Authority / Receiving Office
- PK · PK
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-04-22
- Publication Date
- 2026-08-06
Abstract
The present specification relates to pharmaceutical formulation comprising N-(1-(3- fluoropropyl)azetidin-3-yl)-6((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3Hpyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine, microcrystalline cellulose (MCC) and dicalcium phosphate anhydrous (DCPA), for example tablets with immediate release properties.
Need to check novelty before this filing date? Find Prior Art